Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder

ClinicalTrials.gov ID: NCT07046494

Public ClinicalTrials.gov record NCT07046494. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 4:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of RAP-219 for the Acute Treatment of Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a clinical research study for an investigational drug called RAP-219 in participants with bipolar I disorder. This study is being conducted to determine if RAP-219 is safe and effective in participants experiencing mania associated with bipolar I disorder.

Study identification

NCT ID
NCT07046494
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Rapport Therapeutics Inc.
Industry
Enrollment
253 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 24, 2025
Primary completion
Aug 4, 2026
Completion
Sep 30, 2026
Last update posted
Aug 9, 2026

2025 – 2026

United States locations

U.S. sites
20
U.S. states
10
U.S. cities
20
Facility City State ZIP Site status
Pillar Clinical Research - Little Rock Little Rock Arkansas 72204
Woodland Research Northwest Rogers Arkansas 72758
Inland Psychiatric Medical Group - Chino Chino California 91710
Synergy Clinical Research Center - San Diego Lemon Grove California 91945
Collaborative Neuroscience Research - Los Alamitos Los Alamitos California 90720
NRC Research Institute - Orange Orange California 92868
NeuroBehavioral Hospitals of the Palm Beaches - South Boynton Beach Florida 33426
United Research Institute Hialeah Florida 33012
CenExel - Hollywood Hollywood Florida 33024
Segal Trials - Miami Lakes Medical Research Early Phase, Inpatient & Outpatient Site Miami Lakes Florida 33016
Neuroscience Research Institute at Ambrosia West Palm Beach Florida 33407
CenExel - Decatur Decatur Georgia 30030
Pillar Clinical Research - Chicago Chicago Illinois 60641
CenExel - Gaithersburg Gaithersburg Maryland 20877
Arch Clinical Trials St Louis Missouri 63125
Richmond Behavioral Associates Staten Island New York 10314
New Hope Clinical Research Charlotte North Carolina 28211
Community Clinical Research, Inc. Austin Texas 78754
HD Research - Memorial Hermann Village Houston Texas 77043
Pillar Clinical Research - Richardson Richardson Texas 75080

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07046494, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 9, 2026 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07046494 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →